ICD-10-CM/PCS MS-DRG v34.0 Definitions Manual
![Previous Page [Alt-p]](bakpg.png){kind=small}
![Up a level [Alt-u]](uptop.png){kind=small}
![Next Page [Alt-n]](fwdpg.png){kind=small}
ICD-10-CM/PCS MS-DRG v34.0 Definitions Manual |
||||
| Skip to content | |
|
|
| MDC 17 Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms |
| Lymphoma and Leukemia with Major Procedure |
| Page 2 of 12 |
PRINCIPAL DIAGNOSIS (continued)
| C9130 | Prolymphocytic leukemia of B-cell type not having achieved remission |
| C9131 | Prolymphocytic leukemia of B-cell type, in remission |
| C9132 | Prolymphocytic leukemia of B-cell type, in relapse |
| C9140 | Hairy cell leukemia not having achieved remission |
| C9141 | Hairy cell leukemia, in remission |
| C9142 | Hairy cell leukemia, in relapse |
| C9150 | Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission |
| C9151 | Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission |
| C9152 | Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse |
| C9160 | Prolymphocytic leukemia of T-cell type not having achieved remission |
| C9161 | Prolymphocytic leukemia of T-cell type, in remission |
| C9162 | Prolymphocytic leukemia of T-cell type, in relapse |
| C9190 | Lymphoid leukemia, unspecified not having achieved remission |
| C9191 | Lymphoid leukemia, unspecified, in remission |
| C9192 | Lymphoid leukemia, unspecified, in relapse |
| C91A0 | Mature B-cell leukemia Burkitt-type not having achieved remission |
| C91A1 | Mature B-cell leukemia Burkitt-type, in remission |
| C91A2 | Mature B-cell leukemia Burkitt-type, in relapse |
| C91Z0 | Other lymphoid leukemia not having achieved remission |
| C91Z1 | Other lymphoid leukemia, in remission |
| C91Z2 | Other lymphoid leukemia, in relapse |
| C9200 | Acute myeloblastic leukemia, not having achieved remission |
| C9201 | Acute myeloblastic leukemia, in remission |
| C9202 | Acute myeloblastic leukemia, in relapse |
| C9210 | Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission |
| C9211 | Chronic myeloid leukemia, BCR/ABL-positive, in remission |
| C9212 | Chronic myeloid leukemia, BCR/ABL-positive, in relapse |
| C9220 | Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission |
| C9221 | Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission |
| C9222 | Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse |
| C9230 | Myeloid sarcoma, not having achieved remission |
| C9231 | Myeloid sarcoma, in remission |
| C9232 | Myeloid sarcoma, in relapse |
| C9240 | Acute promyelocytic leukemia, not having achieved remission |
| C9241 | Acute promyelocytic leukemia, in remission |
| C9242 | Acute promyelocytic leukemia, in relapse |
| C9250 | Acute myelomonocytic leukemia, not having achieved remission |
| C9251 | Acute myelomonocytic leukemia, in remission |
| C9252 | Acute myelomonocytic leukemia, in relapse |
| C9260 | Acute myeloid leukemia with 11q23-abnormality not having achieved remission |
| C9261 | Acute myeloid leukemia with 11q23-abnormality in remission |
| C9262 | Acute myeloid leukemia with 11q23-abnormality in relapse |
| C9290 | Myeloid leukemia, unspecified, not having achieved remission |
| C9291 | Myeloid leukemia, unspecified in remission |
| C9292 | Myeloid leukemia, unspecified in relapse |
| C92A0 | Acute myeloid leukemia with multilineage dysplasia, not having achieved remission |
| C92A1 | Acute myeloid leukemia with multilineage dysplasia, in remission |
| C92A2 | Acute myeloid leukemia with multilineage dysplasia, in relapse |
| C92Z0 | Other myeloid leukemia not having achieved remission |
| C92Z1 | Other myeloid leukemia, in remission |
| C92Z2 | Other myeloid leukemia, in relapse |
| C9300 | Acute monoblastic/monocytic leukemia, not having achieved remission |
| C9301 | Acute monoblastic/monocytic leukemia, in remission |
| C9302 | Acute monoblastic/monocytic leukemia, in relapse |
| C9310 | Chronic myelomonocytic leukemia not having achieved remission |
| C9311 | Chronic myelomonocytic leukemia, in remission |
| C9312 | Chronic myelomonocytic leukemia, in relapse |
| C9330 | Juvenile myelomonocytic leukemia, not having achieved remission |
| C9331 | Juvenile myelomonocytic leukemia, in remission |
| C9332 | Juvenile myelomonocytic leukemia, in relapse |
| C9390 | Monocytic leukemia, unspecified, not having achieved remission |
| C9391 | Monocytic leukemia, unspecified in remission |
| C9392 | Monocytic leukemia, unspecified in relapse |
| C93Z0 | Other monocytic leukemia, not having achieved remission |
| C93Z1 | Other monocytic leukemia, in remission |
| C93Z2 | Other monocytic leukemia, in relapse |
| C9400 | Acute erythroid leukemia, not having achieved remission |
| C9401 | Acute erythroid leukemia, in remission |
| C9402 | Acute erythroid leukemia, in relapse |
| C9420 | Acute megakaryoblastic leukemia not having achieved remission |
| C9421 | Acute megakaryoblastic leukemia, in remission |
| C9422 | Acute megakaryoblastic leukemia, in relapse |
| C9430 | Mast cell leukemia not having achieved remission |
| C9431 | Mast cell leukemia, in remission |
| C9432 | Mast cell leukemia, in relapse |
| C9440 | Acute panmyelosis with myelofibrosis not having achieved remission |
| C9441 | Acute panmyelosis with myelofibrosis, in remission |
| C9442 | Acute panmyelosis with myelofibrosis, in relapse |
| C946 | Myelodysplastic disease, not classified |
| C9480 | Other specified leukemias not having achieved remission |
| C9481 | Other specified leukemias, in remission |
| C9482 | Other specified leukemias, in relapse |
| C9500 | Acute leukemia of unspecified cell type not having achieved remission |
| C9501 | Acute leukemia of unspecified cell type, in remission |
| C9502 | Acute leukemia of unspecified cell type, in relapse |
| C9510 | Chronic leukemia of unspecified cell type not having achieved remission |
| C9511 | Chronic leukemia of unspecified cell type, in remission |
| C9512 | Chronic leukemia of unspecified cell type, in relapse |
| C9590 | Leukemia, unspecified not having achieved remission |
| C9591 | Leukemia, unspecified, in remission |
| C9592 | Leukemia, unspecified, in relapse |
| C962 | Malignant mast cell tumor |
| C964 | Sarcoma of dendritic cells (accessory cells) |
| C969 | Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified |
| C96A | Histiocytic sarcoma |
| C96Z | Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue |
| D45 | Polycythemia vera |
| D470 | Histiocytic and mast cell tumors of uncertain behavior |
| D471 | Chronic myeloproliferative disease |
| D479 | Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified |
| D47Z2 | Castleman disease |
| D47Z9 | Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue |
| D6182 | Myelophthisis |
| D7581 | Myelofibrosis |
| D891 | Cryoglobulinemia |
OPERATING ROOM PROCEDURES
0016070 005A4ZZ 00WV0MZ 05HH4DZ 07NG3ZZ 07VJ3DZ 0D1A0JK 0D9840Z 0F154Z3 0SB34ZZ 0W3B4ZZ
| 0016070 | Bypass Cerebral Ventricle to Nasopharynx with Autologous Tissue Substitute, Open Approach |
| 0016071 | Bypass Cerebral Ventricle to Mastoid Sinus with Autologous Tissue Substitute, Open Approach |
| 0016072 | Bypass Cerebral Ventricle to Atrium with Autologous Tissue Substitute, Open Approach |
| 0016073 | Bypass Cerebral Ventricle to Blood Vessel with Autologous Tissue Substitute, Open Approach |
| 0016074 | Bypass Cerebral Ventricle to Pleural Cavity with Autologous Tissue Substitute, Open Approach |
| 0016075 | Bypass Cerebral Ventricle to Intestine with Autologous Tissue Substitute, Open Approach |
| 0016076 | Bypass Cerebral Ventricle to Peritoneal Cavity with Autologous Tissue Substitute, Open Approach |
| 0016077 | Bypass Cerebral Ventricle to Urinary Tract with Autologous Tissue Substitute, Open Approach |
| 0016078 | Bypass Cerebral Ventricle to Bone Marrow with Autologous Tissue Substitute, Open Approach |
| 001607B | Bypass Cerebral Ventricle to Cerebral Cisterns with Autologous Tissue Substitute, Open Approach |
| 00160J0 | Bypass Cerebral Ventricle to Nasopharynx with Synthetic Substitute, Open Approach |
| 00160J1 | Bypass Cerebral Ventricle to Mastoid Sinus with Synthetic Substitute, Open Approach |
| 00160J2 | Bypass Cerebral Ventricle to Atrium with Synthetic Substitute, Open Approach |
| 00160J3 | Bypass Cerebral Ventricle to Blood Vessel with Synthetic Substitute, Open Approach |
| 00160J4 | Bypass Cerebral Ventricle to Pleural Cavity with Synthetic Substitute, Open Approach |
| 00160J5 | Bypass Cerebral Ventricle to Intestine with Synthetic Substitute, Open Approach |
| 00160J6 | Bypass Cerebral Ventricle to Peritoneal Cavity with Synthetic Substitute, Open Approach |
| 00160J7 | Bypass Cerebral Ventricle to Urinary Tract with Synthetic Substitute, Open Approach |
| 00160J8 | Bypass Cerebral Ventricle to Bone Marrow with Synthetic Substitute, Open Approach |
| 00160JB | Bypass Cerebral Ventricle to Cerebral Cisterns with Synthetic Substitute, Open Approach |
| 00160K0 | Bypass Cerebral Ventricle to Nasopharynx with Nonautologous Tissue Substitute, Open Approach |
| 00160K1 | Bypass Cerebral Ventricle to Mastoid Sinus with Nonautologous Tissue Substitute, Open Approach |
| 00160K2 | Bypass Cerebral Ventricle to Atrium with Nonautologous Tissue Substitute, Open Approach |
| 00160K3 | Bypass Cerebral Ventricle to Blood Vessel with Nonautologous Tissue Substitute, Open Approach |
| 00160K4 | Bypass Cerebral Ventricle to Pleural Cavity with Nonautologous Tissue Substitute, Open Approach |
| 00160K5 | Bypass Cerebral Ventricle to Intestine with Nonautologous Tissue Substitute, Open Approach |
| 00160K6 | Bypass Cerebral Ventricle to Peritoneal Cavity with Nonautologous Tissue Substitute, Open Approach |
| 00160K7 | Bypass Cerebral Ventricle to Urinary Tract with Nonautologous Tissue Substitute, Open Approach |
| 00160K8 | Bypass Cerebral Ventricle to Bone Marrow with Nonautologous Tissue Substitute, Open Approach |
| 00160KB | Bypass Cerebral Ventricle to Cerebral Cisterns with Nonautologous Tissue Substitute, Open Approach |
| 0016370 | Bypass Cerebral Ventricle to Nasopharynx with Autologous Tissue Substitute, Percutaneous Approach |
| 0016371 | Bypass Cerebral Ventricle to Mastoid Sinus with Autologous Tissue Substitute, Percutaneous Approach |
| 0016372 | Bypass Cerebral Ventricle to Atrium with Autologous Tissue Substitute, Percutaneous Approach |
| 0016373 | Bypass Cerebral Ventricle to Blood Vessel with Autologous Tissue Substitute, Percutaneous Approach |
| 0016374 | Bypass Cerebral Ventricle to Pleural Cavity with Autologous Tissue Substitute, Percutaneous Approach |
| 0016375 | Bypass Cerebral Ventricle to Intestine with Autologous Tissue Substitute, Percutaneous Approach |
| 0016376 | Bypass Cerebral Ventricle to Peritoneal Cavity with Autologous Tissue Substitute, Percutaneous Approach |
| 0016377 | Bypass Cerebral Ventricle to Urinary Tract with Autologous Tissue Substitute, Percutaneous Approach |
| 0016378 | Bypass Cerebral Ventricle to Bone Marrow with Autologous Tissue Substitute, Percutaneous Approach |
| 001637B | Bypass Cerebral Ventricle to Cerebral Cisterns with Autologous Tissue Substitute, Percutaneous Approach |
| 00163J0 | Bypass Cerebral Ventricle to Nasopharynx with Synthetic Substitute, Percutaneous Approach |
| 00163J1 | Bypass Cerebral Ventricle to Mastoid Sinus with Synthetic Substitute, Percutaneous Approach |
| 00163J2 | Bypass Cerebral Ventricle to Atrium with Synthetic Substitute, Percutaneous Approach |
| 00163J3 | Bypass Cerebral Ventricle to Blood Vessel with Synthetic Substitute, Percutaneous Approach |
| 00163J4 | Bypass Cerebral Ventricle to Pleural Cavity with Synthetic Substitute, Percutaneous Approach |
| 00163J5 | Bypass Cerebral Ventricle to Intestine with Synthetic Substitute, Percutaneous Approach |
| 00163J6 | Bypass Cerebral Ventricle to Peritoneal Cavity with Synthetic Substitute, Percutaneous Approach |
| 00163J7 | Bypass Cerebral Ventricle to Urinary Tract with Synthetic Substitute, Percutaneous Approach |
| 00163J8 | Bypass Cerebral Ventricle to Bone Marrow with Synthetic Substitute, Percutaneous Approach |
| 00163JB | Bypass Cerebral Ventricle to Cerebral Cisterns with Synthetic Substitute, Percutaneous Approach |
| 00163K0 | Bypass Cerebral Ventricle to Nasopharynx with Nonautologous Tissue Substitute, Percutaneous Approach |
| 00163K1 | Bypass Cerebral Ventricle to Mastoid Sinus with Nonautologous Tissue Substitute, Percutaneous Approach |
| 00163K2 | Bypass Cerebral Ventricle to Atrium with Nonautologous Tissue Substitute, Percutaneous Approach |
| 00163K3 | Bypass Cerebral Ventricle to Blood Vessel with Nonautologous Tissue Substitute, Percutaneous Approach |
| 00163K4 | Bypass Cerebral Ventricle to Pleural Cavity with Nonautologous Tissue Substitute, Percutaneous Approach |
| 00163K5 | Bypass Cerebral Ventricle to Intestine with Nonautologous Tissue Substitute, Percutaneous Approach |
| 00163K6 | Bypass Cerebral Ventricle to Peritoneal Cavity with Nonautologous Tissue Substitute, Percutaneous Approach |
| 00163K7 | Bypass Cerebral Ventricle to Urinary Tract with Nonautologous Tissue Substitute, Percutaneous Approach |
| 00163K8 | Bypass Cerebral Ventricle to Bone Marrow with Nonautologous Tissue Substitute, Percutaneous Approach |
| 00163KB | Bypass Cerebral Ventricle to Cerebral Cisterns with Nonautologous Tissue Substitute, Percutaneous Approach |
| 001U074 | Bypass Spinal Canal to Pleural Cavity with Autologous Tissue Substitute, Open Approach |
| 001U076 | Bypass Spinal Canal to Peritoneal Cavity with Autologous Tissue Substitute, Open Approach |
| 001U077 | Bypass Spinal Canal to Urinary Tract with Autologous Tissue Substitute, Open Approach |
| 001U079 | Bypass Spinal Canal to Fallopian Tube with Autologous Tissue Substitute, Open Approach |
| 001U0J4 | Bypass Spinal Canal to Pleural Cavity with Synthetic Substitute, Open Approach |
| 001U0J6 | Bypass Spinal Canal to Peritoneal Cavity with Synthetic Substitute, Open Approach |
| 001U0J7 | Bypass Spinal Canal to Urinary Tract with Synthetic Substitute, Open Approach |
| 001U0J9 | Bypass Spinal Canal to Fallopian Tube with Synthetic Substitute, Open Approach |
| 001U0K4 | Bypass Spinal Canal to Pleural Cavity with Nonautologous Tissue Substitute, Open Approach |
| 001U0K6 | Bypass Spinal Canal to Peritoneal Cavity with Nonautologous Tissue Substitute, Open Approach |
| 001U0K7 | Bypass Spinal Canal to Urinary Tract with Nonautologous Tissue Substitute, Open Approach |
| 001U0K9 | Bypass Spinal Canal to Fallopian Tube with Nonautologous Tissue Substitute, Open Approach |
| 001U374 | Bypass Spinal Canal to Pleural Cavity with Autologous Tissue Substitute, Percutaneous Approach |
| 001U376 | Bypass Spinal Canal to Peritoneal Cavity with Autologous Tissue Substitute, Percutaneous Approach |
| 001U377 | Bypass Spinal Canal to Urinary Tract with Autologous Tissue Substitute, Percutaneous Approach |
| 001U379 | Bypass Spinal Canal to Fallopian Tube with Autologous Tissue Substitute, Percutaneous Approach |
| 001U3J4 | Bypass Spinal Canal to Pleural Cavity with Synthetic Substitute, Percutaneous Approach |
| 001U3J6 | Bypass Spinal Canal to Peritoneal Cavity with Synthetic Substitute, Percutaneous Approach |
| 001U3J7 | Bypass Spinal Canal to Urinary Tract with Synthetic Substitute, Percutaneous Approach |
| 001U3J9 | Bypass Spinal Canal to Fallopian Tube with Synthetic Substitute, Percutaneous Approach |
| 001U3K4 | Bypass Spinal Canal to Pleural Cavity with Nonautologous Tissue Substitute, Percutaneous Approach |
| 001U3K6 | Bypass Spinal Canal to Peritoneal Cavity with Nonautologous Tissue Substitute, Percutaneous Approach |
| 001U3K7 | Bypass Spinal Canal to Urinary Tract with Nonautologous Tissue Substitute, Percutaneous Approach |
| 001U3K9 | Bypass Spinal Canal to Fallopian Tube with Nonautologous Tissue Substitute, Percutaneous Approach |
| 00500ZZ | Destruction of Brain, Open Approach |
| 00503ZZ | Destruction of Brain, Percutaneous Approach |
| 00504ZZ | Destruction of Brain, Percutaneous Endoscopic Approach |
| 00510ZZ | Destruction of Cerebral Meninges, Open Approach |
| 00513ZZ | Destruction of Cerebral Meninges, Percutaneous Approach |
| 00514ZZ | Destruction of Cerebral Meninges, Percutaneous Endoscopic Approach |
| 00520ZZ | Destruction of Dura Mater, Open Approach |
| 00523ZZ | Destruction of Dura Mater, Percutaneous Approach |
| 00524ZZ | Destruction of Dura Mater, Percutaneous Endoscopic Approach |
| 00570ZZ | Destruction of Cerebral Hemisphere, Open Approach |
| 00573ZZ | Destruction of Cerebral Hemisphere, Percutaneous Approach |
| 00574ZZ | Destruction of Cerebral Hemisphere, Percutaneous Endoscopic Approach |
| 00580ZZ | Destruction of Basal Ganglia, Open Approach |
| 00583ZZ | Destruction of Basal Ganglia, Percutaneous Approach |
| 00584ZZ | Destruction of Basal Ganglia, Percutaneous Endoscopic Approach |
| 00590ZZ | Destruction of Thalamus, Open Approach |
| 00593ZZ | Destruction of Thalamus, Percutaneous Approach |
| 00594ZZ | Destruction of Thalamus, Percutaneous Endoscopic Approach |
| 005A0ZZ | Destruction of Hypothalamus, Open Approach |
| 005A3ZZ | Destruction of Hypothalamus, Percutaneous Approach |
|
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 02 Nov 2016 09:53:07 PROD, CMS, code-revision=31, description-revision=86 |